First Clinical Study to Evaluate Safety, Tolerability & PK of DX243 in Healthy Volunteers and Patients With Hearing Loss

NCT07637981 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-related Hearing Loss

Interventions

DRUG: DX243
DRUG: Placebo

Sponsor

Dendrogenix